<DOC>
	<DOCNO>NCT00468364</DOCNO>
	<brief_summary>Long-acting insulin inject bedtime may cause hypoglycemia ( low blood sugar ) night patient diabetes . The aim study 1 ) compare dynamic characteristic long-acting insulin analog glargine NPH insulin placebo night early morning hour , 2 ) investigate difference glucose metabolism bedtime glargine versus NPH insulin induce hypoglycemia .</brief_summary>
	<brief_title>Comparison Insulin Glargine NPH Insulin Night Hypoglycemia Type 2 Diabetes</brief_title>
	<detailed_description>Patients advance type 2 diabetes like type 1 diabetes risk defective glucose counterregulation hypoglycemia unawareness , component hypoglycemia-associated autonomic failure resultant vicious cycle recurrent iatrogenic hypoglycemia . This may explain iatrogenic hypoglycemia become limit glycemic control patient approach insulin-deficient end spectrum type 2 diabetes . Compared Neutral Protamin Hagedorn ( NPH ) insulin glargine new long-acting peakless analogue low incidence nocturnal hypoglycemia potential decrease frequency hypoglycemia insulin therapy . Modern type 2 diabetes therapy guideline recommend insulin increase population patient . There doubt type 2 diabetic patient suffer hypoglycemia insulin therapy , however clear whether extensive study hypoglycemia type 1 patient apply also type 2 diabetes . Recent report indicate type 2 diabetic patient long duration react similarly hypoglycemic clamp type 1 diabetic patient well control type 2 diabetic even favorable threshold counter-regulatory hormone secretion . On basis consideration aim study 1 ) precisely define mechanism hypoglycemia type 2 diabetes , 2 ) investigate difference glucose lactate metabolism bedtime NPH insulin versus glargine . To address objective use hypoglycemic clamping technique combine infusion stable isotope glucose lactate non-invasive measurement muscle flow characteristic hypoglycemia .</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Type 2 Diabetes mellitus Therapy may either insulin alone combination oral antidiabetic agent Metabolic control HbA1c value &lt; 10 % Other type 2 diabetes Pregnancy Systemic Corticosteroids , Betablockers Clinically relevant cardiovascular , gastrointestinal , hepatic , neurologic , endocrine , haematological major disease make implementation protocol interpretation study result difficult History drug alcohol abuse Impaired renal function ( serum creatinine &gt; 1.3 mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Hypoglycemia , bedtime insulin , long-acting insulin</keyword>
</DOC>